Literature DB >> 10395878

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

D Goldblatt1, P Richmond, E Millard, C Thornton, E Miller.   

Abstract

The significance of reduced antibody responses to the Haemophilus influenzae type b (Hib) component of acellular pertussis-containing combination vaccines (DTaP-Hib) is unclear. A DTaP-Hib vaccine evaluated in infants vaccinated at ages 2, 3, and 4 months showed reduced anti-Hib polysaccharide IgG (geometric mean concentration [GMC], 1.23 microgram/mL; 57%, >1.0 microgram/mL). Polyribitolribosyl phosphate (PRP) and Hib conjugate (PRP-T) vaccine given as a booster during the second year of life was evaluated for the presence of immunological memory. After boosting, most children achieved anti-PRP IgG >1.0 microgram/mL, although the GMC was higher with PRP-T (88.5 microgram/mL) than with PRP vaccine (7.86 microgram/mL, P<.001). The GMC of the PRP group was higher than anticipated for naive PRP recipients of the same age. PRP-specific IgG avidity was significantly higher after boosting than after priming, providing further evidence for the generation of memory. Despite reduced immunogenicity, DTaP-Hib combination vaccines appear to prime for immunologic memory.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395878     DOI: 10.1086/314901

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Conjugate vaccines.

Authors:  D Goldblatt
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease.

Authors:  P Clarke; P J Powell; D Goldblatt; M J Robinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

Review 3.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

4.  Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.

Authors:  Elizabeth Miller; Nick Andrews; Pauline Waight; Helen Findlow; Lindsey Ashton; Anna England; Elaine Stanford; Mary Matheson; Joanna Southern; Elizabeth Sheasby; David Goldblatt; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2010-12-29

5.  DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.

Authors:  M H Slack; S Cade; D Schapira; R J Thwaites; A Crowley-Luke; J Southern; R Borrow; E Miller
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 6.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life.

Authors:  M H Slack; D Schapira; R J Thwaites; M Burrage; J Southern; D Goldblatt; E Miller
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

8.  Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.

Authors:  Ray Borrow; David Goldblatt; Adam Finn; Joanna Southern; Lindsey Ashton; Nick Andrews; Gouri Lal; Christine Riley; Rukhsana Rahim; Keith Cartwright; Geraldine Allan; Elizabeth Miller
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.

Authors:  Shannon L Harris; W James King; Wendy Ferris; Dan M Granoff
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine.

Authors:  Patricia Gómez-de-León; F Javier Díaz-García; Alberto Villaseñor-Sierra; Jorge Segura; Martha I Carranza; José Luis Arredondo-Garcia; José Ignacio Santos
Journal:  Clin Vaccine Immunol       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.